Skip to main contentSkip to navigation
Sirius Investors
Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd.

SMDPY
OTCHealthcare

Sumitomo Pharma Co., Ltd. (SMDPY) Investment Research Dashboard

About Sumitomo Pharma Co., Ltd. (SMDPY) stock analysis

Get live SMDPY stock price $9.25, comprehensive Sumitomo Pharma Co., Ltd. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time SMDPY stock data and investment insights.

9.25
0.00%Today
Market Cap
4.15B
Volume
1.40K
52W High
24.48
52W Low
7.66

Loading chart data...

Sumitomo Pharma Co., Ltd. (SMDPY) Overview

Sumitomo Pharma Co., Ltd. (SMDPY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, SMDPY trades at $9.25 with a market capitalization of 4.15B . Over the past 52 weeks, SMDPY has traded between $7.66 and $24.48 , with the current price positioned at approximately 9% of this range...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 4.15B
  • Current price: $9.25
  • 52-week range: $7.66 - $24.48
  • P/E ratio: 5.07

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Sumitomo Pharma Co., Ltd. operates as a global entity focused on the development, manufacturing, and distribution of a diverse range of products. Its primary offerings include pharmaceutical drugs, food components and additives, and veterinary treatm...

Company Information

CEO
Toru Kimura
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4980

Contact Information

Address
6-8, Doshomachi 2-chome
Country
JP

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 5.1)

Lower volatility stock (Beta: 0.48) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Sumitomo Pharma Co., Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Sumitomo Pharma Co., Ltd.
  • Investors should consider how Sumitomo Pharma Co., Ltd. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

4.15B

P/E Ratio (TTM)

5.07

Beta

0.48

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

80/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+5.7%+6.1%19.3
98/100⭐⭐⭐⭐⭐
Communication Services+1.4%+2.9%+4.3%22.2
86/100⭐⭐⭐⭐⭐
Healthcare+0.7%+3.3%+3.5%24.1
80/100⭐⭐⭐⭐⭐
Basic Materials+0.4%+1.1%-0.2%25.2
56/100⭐⭐⭐⭐
Consumer Defensive-0.2%+1.7%+1.2%29.7
56/100⭐⭐⭐⭐
Real Estate-0.5%-0.1%-1.6%29.2
43/100⭐⭐⭐
Energy-2.1%-5.8%-5.1%19.1
39/100⭐⭐
Utilities-1.0%-3.0%-5.9%26.8
28/100⭐⭐
Industrials+0.6%+1.7%-11.2%30.1
26/100⭐⭐
Consumer Cyclical+0.5%-0.4%-6.3%43.0
21/100
Technology+0.6%-2.3%-9.6%40.7
17/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.